Showing 141 - 160 results of 32,240 for search '(( significant cause increase ) OR ( significant ((side decrease) OR (step decrease)) ))', query time: 2.10s Refine Results
  1. 141
  2. 142

    Table1_One year of treatment with elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis homozygous for the F508del mutation causes a significant increase in liver biochemical indexes.docx by Alice Castaldo (9956004)

    Published 2024
    “…</p><p>Results: Beyond the improvement of BMI and lung function with LI treatment and even more with ETI, we found that the 3 years of LI treatment significantly improved liver function parameters (total and conjugated bilirubin, ALT, AP, and GGT), while the subsequent ETI treatment caused a significant increase of such parameters.…”
  3. 143

    Table2_One year of treatment with elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis homozygous for the F508del mutation causes a significant increase in liver biochemical indexes.docx by Alice Castaldo (9956004)

    Published 2024
    “…</p><p>Results: Beyond the improvement of BMI and lung function with LI treatment and even more with ETI, we found that the 3 years of LI treatment significantly improved liver function parameters (total and conjugated bilirubin, ALT, AP, and GGT), while the subsequent ETI treatment caused a significant increase of such parameters.…”
  4. 144
  5. 145

    A possible cause of epistaxis: increased masked hypertension prevalence in patients with epistaxis by Baran Acar (10419356)

    Published 2022
    “…Conclusion This study demonstrates increased masked hypertension prevalence in patients with epistaxis. …”
  6. 146
  7. 147
  8. 148
  9. 149
  10. 150
  11. 151

    Fig 7 - by Henning Carstens (13132801)

    Published 2022
    Subjects:
  12. 152
  13. 153

    Fig 1 - by Henning Carstens (13132801)

    Published 2022
    Subjects:
  14. 154
  15. 155
  16. 156

    Fig 2 - by Henning Carstens (13132801)

    Published 2022
    Subjects:
  17. 157
  18. 158
  19. 159
  20. 160